PAMS
RDY icon

Pinpoint Asset Management (Singapore)’s Dr. Reddy's Laboratories RDY Stock Holding History

Pinpoint Asset Management (Singapore)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-340,497
Closed -$4.76M – 162
2025
Q3 		$4.76M Buy
+340,497
New +$4.9M 0.85% 22

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Pinpoint Asset Management (Singapore)'s RDY Position: Q4 2025 in Review

Pinpoint Asset Management (Singapore) sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 340,497 shares — an estimated $4.76M sold.

Pinpoint Asset Management (Singapore) first reported a position in RDY in Q3 2025 and held it in 1 quarter. The position peaked at $4.76M in Q3 2025. 236 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

  • Pinpoint Asset Management (Singapore) reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
  • Pinpoint Asset Management (Singapore) sold 340,497 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $4.76M.
  • Pinpoint Asset Management (Singapore) first reported a position in Dr. Reddy's Laboratories in Q3 2025 and held it in 1 quarter.
  • Pinpoint Asset Management (Singapore)'s Dr. Reddy's Laboratories position peaked at $4.76M in Q3 2025.
  • 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on Pinpoint Asset Management (Singapore)'s 13F filing for Q4 2025, filed 13 Feb 2026.